Papercurve

🎉 I announced the launch of OPDP Resources last week — and I’m thrilled that many have already started their 7-day trial! But maybe you’re wondering: How would I actually use it? Here are three real-world examples 👇 Example 1: It's 2025. FDA drops 60 letters in a single month (true story). You have little time to make sense of which ones are relevant to your materials. → Instead of reading through all 60, browse concise summaries and filter instantly by material type, audience, or violation. Example 2: You’re the first regulatory ad/promo hire at a small company two months from launch. You’re prepping an internal FDA 101 for your cross-functional team and want examples in your same therapeutic area. → Filter by therapeutic area and violation type to find exactly what you need. Example 3: Marketing wants to use the headline “UNSURPASSED EFFICACY.” It’s technically true that no competitor has surpassed your trial results — but how would FDA view it? → Pull up the three prior letters where FDA cited “unsurpassed” as a superiority claim. Walk into PRC armed with precedent. 🔍 OPDP Resources makes these scenarios easy to handle — with filters, summaries, and the full letter text all in one place, available anytime. 👉 Try it free for 7 days at opdpresources.com For teams: enterprise access and multi-user trials are also available. Just send me a note.

KEEP Cold named one of TIME’s Best Inventions of 2025 We’re proud to officially introduce KEEP Cold — the world’s first intelligent in-home cold chain system — and to share that it’s been recognized by TIME as one of the Best Inventions of 2025. Five years after our original KEEP device was honored by TIME, KEEP Cold expands that vision: bringing medical-grade temperature precision, AI-powered support, and intelligent monitoring into the home to protect today’s most advanced therapies. We built KEEP Cold to close the last mile of cold chain, making therapy integrity visible, reliable, and personal. Learn more: discoverkeep.com/keep-cold

I am excited to share an open position on my team for an Associate Director, AI Strategy and Operations. This role will support AI strategy development at AbbVie with cross-functional impact across the enterprise. Join us in our mission to harness AI to accelerate the delivery of life-changing medicines. #hiring

🚀 Introducing OPDP Resources — The Expert Way to Search FDA Enforcement Letters After months of development, feedback, and fine-tuning, I’m thrilled to share that OPDP Resources is now live. Built for regulatory and promotional review professionals, OPDP Resources brings together nearly 30 years of FDA promotion enforcement letters (OPDP, DDMAC, and APLB) into a modern platform. What sets it apart: ✅ Streamlined, Visual Interface – Designed for deeper insight and ease of use, not just document retrieval ✅ Advanced Search & Filters – Instantly find letters by product, company, therapeutic area, violation type, media format, and more ✅ Smart, Concise Summaries – Grasp key issues at a glance ✅ Full Content Access – Includes both downloadable materials and OCR-cleaned text for easy copy/paste ✅ Integrated Media Viewer – Watch 85+ TV ads and digital videos cited in enforcement actions (1997-present) Whether you’re conducting promotional review, training new staff, or tracking enforcement trends, OPDP Resources was built to make compliance research faster and more intuitive. 👉 Explore it here: www.opdpresources.com If you work in pharma ad/promo, regulatory affairs, or medical-legal review, I’d love your thoughts and feedback.

Right now, Canadian patients wait approximately two years after Health Canada approval to access new treatments and vaccines—and that's simply too long. By working together across governments, industry, and health partners, we have a real opportunity to reduce these delays and deliver better outcomes for patients nationwide.

Join an exciting team with big plans.

👉 Overwhelmed by last month’s FDA enforcement blitz? 🔎 Next Tuesday, meet OPDP Resources—the modern, user-friendly database covering nearly 30 years of FDA enforcement letters (OPDP/DDMAC + APLB). Stop drowning in PDFs. 📑 Rapidly research precedents, dig into enforcement patterns, and find exactly what you and your reg ad/promo team need—in seconds. Stay tuned!